Is there a link between the amount of glucose produced and the time of the day that a person works?… 

Low blood sugar episodes can increase the incidence of developing dementia, while dementia may increase the risk of having low blood sugar, creating a vicious cycle….

The device could detect lung cancer as well…. 

We are moving closer to the full bore effect of the Affordable Care Act and although there are many opinions as to how good or bad the idea is, it has increased healthcare coverage for many Americans. Part of the program’s positive ideas includes more emphasis on prevention and wellness, …

  With this week’s Homerun Slides set, we tackle a new topic, Workplace Wellness, covering topics including: Rising Costs of Illness; Recent Trends in Workplace Wellness; and the Rationale for Wellness Programs….

This week I was talking to a group of physician interns about food choices for diabetes and was trying to explain the value of a low carbohydrate program. During the discussion one of the students interrupted to advise the group that eating less carbohydrates means more fat and that will …

mySugr GmbH iOS and Android/Free This popular app is now available for Android also. The app uses the "gamification" concept as well as a sometimes cheeky digital icon to motivate patients. The "Companion" helps document day-to-day life (like a diabetes diary), provides feedback and keeps them motivated. Points are earned …

New Obesity Drug Now Available Eisai and Arena Pharmaceuticals’ obesity drug Belviq is now available in the U.S. Belviq (lorcaserin) is a 5HT2c-receptor agonist that promotes satiety after meals and reduces sensations of hunger before meals.

  New Guidelines for Type 2 Diabetes in Youth  Get the new clinical practice guidelines from the American Academy of Pediatrics for the management of type 2 diabetes in children and adolescents. Youth Guidelines Type 2(pdf) 

Data on 1,479 patients with type 2 diabetes and stable coronary disease revealed 24.1% of those who received insulin-providing medications to regulate blood glucose levels developed peripheral arterial disease at 4.6 years, compared with 16.9% in those who took insulin-sensitizing drugs. Researchers also found patients on insulin sensitizers showed reduced …